Side Effects of Pulmonary Hypertension Medications

Trial ID or NCT#

NCT01571713

Status

not recruiting iconNOT RECRUITING

Purpose

The study seeks to analyze the patient reported effects of pulmonary hypertension medications and compare these with the side effects described on the package inserts. Side effects for these PH medications have been described in the adult population, but have never been described in the pediatric population. This information can better improve patient care and be used to characterize the side effects resultant from these medications.

Official Title

Patient Reported Side Effects of Pulmonary Hypertension (PH) Medications

Eligibility Criteria

Ages Eligible for Study: Younger than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - pulmonary hypertension - currently taking at least one of the following PH medications (Bosentan, Epoprostenol, Letairis, Sildenafil, Tadalafil, Treprostinil, Ventaris)
Exclusion Criteria:
  1. - >18 years

Contact us to find out if this trial is right for you.

Contact

Jeffrey Feinstein, MD, MPH
650-723-7913